These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5396909)

  • 21. Causes of hyperuricaemia.
    Scott JT
    Proc R Soc Med; 1969 Aug; 62(8):851-3. PubMed ID: 5810319
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possible clinical use of benziodarone].
    Klabusay L; Raska P; Vykydal M; Pĕgrímová E; Duda V
    Fysiatr Revmatol Vestn; 1972 Dec; 50(6):352-7. PubMed ID: 4674180
    [No Abstract]   [Full Text] [Related]  

  • 23. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ; Herrick N
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract]   [Full Text] [Related]  

  • 24. [Benziodarone in the treatment of hyperuricemia].
    Ravera M
    Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of benziodaron on purine metabolism in gout patients and healthy subjects].
    Müller MM; Bresnik W
    Klin Wochenschr; 1972 Nov; 50(21):1015-6. PubMed ID: 4637344
    [No Abstract]   [Full Text] [Related]  

  • 26. The purine revolution.
    Lesch M
    N Engl J Med; 1970 Nov; 283(22):1221-2. PubMed ID: 4319627
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575
    [No Abstract]   [Full Text] [Related]  

  • 29. An enzyme defect in metabolic gout.
    Emmerson BT
    Ann Intern Med; 1968 Mar; 68(3):707-8. PubMed ID: 5643688
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the biochemistry and pathogenesis of gout].
    Bäumer A; Susić D; Reese GM
    Hippokrates; 1968 Feb; 39(4):117-24. PubMed ID: 4886176
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic aberrations in gout.
    Seegmiller JE
    Clin Orthop Relat Res; 1970; 71():87-98. PubMed ID: 5270558
    [No Abstract]   [Full Text] [Related]  

  • 32. Views on the pathogenesis and management of primary gout--1971.
    Gutman AB
    J Bone Joint Surg Am; 1972 Mar; 54(2):357-72. PubMed ID: 4568494
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic aspects in gout.
    Alvsaker JO
    Scand J Rheumatol Suppl; 1984; 53():54-63. PubMed ID: 6330884
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the modification of purine metabolism through azathioprine].
    Frank O; Partsch G; Altmann H
    Z Rheumatol; 1974; 33(5):163-71. PubMed ID: 4152726
    [No Abstract]   [Full Text] [Related]  

  • 35. The behavior of oxypurines in human primary gout.
    Aleo MF; Pompucci G; D'Amato MS; Marcolongo R; Marinello E
    Quad Sclavo Diagn; 1983 Jun; 19(2):235-41. PubMed ID: 6676773
    [No Abstract]   [Full Text] [Related]  

  • 36. [Endogenous synthesis and renal excretion of uric acid in patients with primary gout].
    Cirla E; Chériè Lignière G
    Reumatismo; 1969; 21(4):139-51. PubMed ID: 5404860
    [No Abstract]   [Full Text] [Related]  

  • 37. [Uric acid and gout].
    Keller H
    Med Lab (Stuttg); 1975 Apr; 28(4):73-81 contd. PubMed ID: 1177801
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemistry of gout, with special reference to the etiology of hyperuricemia].
    Kumagai A
    Geka Chiryo; 1970 Mar; 22(3):278-82. PubMed ID: 5467644
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyltransferase in a gouty family with partial deficiency of the enzyme.
    Sperling O; Boer P; Eilam G; de Vries A
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):72-5. PubMed ID: 5041350
    [No Abstract]   [Full Text] [Related]  

  • 40. A specific enzyme defect in gout associated with overproduction of uric acid.
    Kelley WN; Rosenbloom FM; Henderson JF; Seegmiller JE
    Proc Natl Acad Sci U S A; 1967 Jun; 57(6):1735-9. PubMed ID: 4291947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.